Argenica Therapeutics LtdASX: AGN

Quarterly Activities/Appendix 4C Cash Flow Report

· Issued by Argenica Therapeutics Ltd via ASX

Filed with ASX ·

ASX ANNOUNCEMENT APPENDIX 4C – 30 SEPTEMBER 2026 QUARTERLY ACTIVITIES & CASHFLOW REPORT Highlights: • Advanced preparations for a late-stage trial in moderate to severe acute ischaemic stroke (AIS) patients. A global stroke Clinical Advisory Committee convened, where international experts...

View Attachment

6ix is reading this filing.

Argenica Therapeutics Ltd on 6ix

Earlier from Argenica Therapeutics

All Argenica Therapeutics news releases